Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Postoperative radiotherapy in periampullary cancers: a brief review.

Bahl A, Bhattacharyya T, Kapoor R, Singh OA, Parsee T, Sharma SC.

J Gastrointest Cancer. 2013 Mar;44(1):111-4. doi: 10.1007/s12029-012-9421-2. Review.

PMID:
22843209
2.

Adjuvant chemoradiotherapy in periampullary cancers--Where does it stand with conformal radiotherapy: A single institution experience.

Kapoor R, Bahl A, Bhattacharyya T, Gupta R, Oinam AS.

J Cancer Res Ther. 2015 Apr-Jun;11(2):433-7. doi: 10.4103/0973-1482.144353.

4.

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.

Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e.

PMID:
19092348
5.

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.

Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

Clin Transl Oncol. 2012 May;14(5):391-5. doi: 10.1007/s12094-012-0814-2.

PMID:
22551547
6.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J.

Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4.

7.

Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?

Shyr YM, Su CH, Lo SS, Wang HC, Lui WY.

Am Surg. 1995 Apr;61(4):288-93.

PMID:
7893088
8.

Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, Ten Hagen TL.

Eur J Surg Oncol. 2012 Nov;38(11):1058-64. doi: 10.1016/j.ejso.2012.04.013. Epub 2012 May 24.

PMID:
22633450
9.

Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report.

Mehta VK, Fisher GA, Ford JM, Poen JC, Vierra MA, Oberhelman HA, Bastidas AJ.

Arch Surg. 2001 Jan;136(1):65-9.

PMID:
11146780
10.

Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.

de Castro SM, Kuhlmann KF, van Heek NT, Busch OR, Offerhaus GJ, van Gulik TM, Obertop H, Gouma DJ.

J Gastrointest Surg. 2004 Nov;8(7):775-84; discussion 784.

PMID:
15531230
11.

Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.

O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. Epub 2005 Jun 22.

PMID:
15978737
12.

Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):436-41. doi: 10.1016/j.ijrobp.2008.11.067. Epub 2009 Apr 23.

PMID:
19394162
13.

Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.

Katz MH, Bouvet M, Al-Refaie W, Gilpin EA, Moossa AR.

Hepatogastroenterology. 2004 May-Jun;51(57):842-6.

PMID:
15143931
14.

Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.

Hoffman JP, Cooper HS, Young NA, Pendurthi TK.

J Hepatobiliary Pancreat Surg. 1998;5(3):251-4. Review.

PMID:
9880771
15.

Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.

Erdmann JI, Eskens FA, Vollmer CM, Kok NF, Groot Koerkamp B, Biermann K, van Eijck CH.

Ann Surg Oncol. 2015 Jul;22(7):2401-7. doi: 10.1245/s10434-014-4267-4. Epub 2014 Dec 12. Review.

PMID:
25503345
16.

Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.

van der Zee JA, ten Hagen TL, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, van Eijck CH.

Eur J Cancer. 2010 Dec;46(18):3393-9. doi: 10.1016/j.ejca.2010.07.024. Epub 2010 Aug 17.

PMID:
20724141
17.

Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.

Acharya A, Markar SR, Sodergren MH, Malietzis G, Darzi A, Athanasiou T, Khan AZ.

Br J Surg. 2017 Jun;104(7):814-822. doi: 10.1002/bjs.10563. Review.

PMID:
28518410
18.

[Clinico-pathological characteristics of surgical effect on periampullary cancers: report of 631 cases].

Shao YF, Wu TC, Shan Y, Wu JX, Wang X, Zhao P.

Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):510-3. Chinese.

PMID:
15949327
19.

Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.

Chang MC, Chang YT, Sun CT, Chiu YF, Lin JT, Tien YW.

World J Surg. 2007 May;31(5):1135-41.

PMID:
17420962
20.

Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.

Pomianowska E, Grzyb K, Westgaard A, Clausen OP, Gladhaug IP.

Eur J Surg Oncol. 2012 Nov;38(11):1043-50. doi: 10.1016/j.ejso.2012.07.113. Epub 2012 Aug 9.

PMID:
22883964

Supplemental Content

Support Center